SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-20-162327
Filing Date
2020-06-05
Accepted
2020-06-05 17:23:12
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 d938215ds3.htm S-3 480334
2 EX-1.2 d938215dex12.htm EX-1.2 184958
3 EX-4.3 d938215dex43.htm EX-4.3 310234
4 EX-4.5 d938215dex45.htm EX-4.5 101358
5 EX-4.6 d938215dex46.htm EX-4.6 100841
6 EX-4.7 d938215dex47.htm EX-4.7 88101
7 EX-5.1 d938215dex51.htm EX-5.1 29348
8 EX-23.1 d938215dex231.htm EX-23.1 2216
9 GRAPHIC g938215g11w36.jpg GRAPHIC 42915
10 GRAPHIC g938215g22j92.jpg GRAPHIC 3433
11 GRAPHIC g938215g33g69.jpg GRAPHIC 115119
12 GRAPHIC g938215g78e63.jpg GRAPHIC 116911
  Complete submission text file 0001193125-20-162327.txt   1668919
Mailing Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 333 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-243-5555
NGM BIOPHARMACEUTICALS INC (Filer) CIK: 0001426332 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-238991 | Film No.: 20947379
SIC: 2834 Pharmaceutical Preparations